Anti-TNFα is a mainstream therapy in certain autoimmune conditions (e.g., IBD and psoriasis); however, it may be associated with increased susceptibility to infections and a lower vaccine response [44]. This evidence concerns the gene TNF and inflammatory bowel disease.